A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Item
http://www.wikidata.org/entity/Q37029462
Neutrophil function in systemic lupus erythematosus and other collagen diseasesInhibition of polymorphonuclear leucocyte functions in vivo by Yersinia enterocolitica lipopolysaccharide.Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol.Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).Formyl peptide-induced chemotaxis of human polymorphonuclear leukocytes does not require either marked changes in cytosolic calcium or specific granule discharge. Role of formyl peptide receptor reexpression (or recycling).Production of chemotactic activity for polymorphonuclear leukocytes by cultured rat hepatocytes exposed to ethanolActivation of the complement system in patients with porphyrias after irradiation in vivo.Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitisAntiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro.Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs. Inhibition by decomplementation in vivo.Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm lightComplement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis.Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.Evidence of complement catabolism in experimental acute pancreatitis.
P2860

A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Item
http://www.wikidata.org/entity/Q37029462
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A specific inhibitor of comple ...... systemic lupus erythematosus.
@en
A specific inhibitor of complement
@nl
type
label
A specific inhibitor of comple ...... systemic lupus erythematosus.
@en
A specific inhibitor of complement
@nl
prefLabel
A specific inhibitor of comple ...... systemic lupus erythematosus.
@en
A specific inhibitor of complement
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A specific inhibitor of comple ...... systemic lupus erythematosus.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932